Manning & Napier Group, LLC Merck & Co., Inc. Transaction History

Manning & Napier Group, LLC

  • $8.76 Billion
  • Q1 2024

A detailed history of Manning & Napier Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Manning & Napier Group, LLC holds 433,356 shares of MRK stock, worth $43 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
433,356
Previous 477,808 9.3%
Holding current value
$43 Million
Previous $52.1 Million 9.77%
% of portfolio
0.65%
Previous 0.62%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024
SELL
$113.24 - $131.95 $5.03 Million - $5.87 Million
-44,452 Reduced 9.3%
433,356 $57.2 Million
Q4 2023

Jan 19, 2024
SELL
$100.18 - $109.02 $6.89 Million - $7.49 Million
-68,741 Reduced 12.58%
477,808 $52.1 Million
Q3 2023

Oct 20, 2023
SELL
$102.95 - $114.33 $2.01 Million - $2.23 Million
-19,496 Reduced 3.44%
546,549 $56.3 Million
Q2 2023

Jul 26, 2023
BUY
$108.61 - $118.38 $5.02 Million - $5.47 Million
46,220 Added 8.89%
566,045 $65.3 Million
Q1 2023

Apr 17, 2023
SELL
$102.94 - $114.86 $268,879 - $300,014
-2,612 Reduced 0.5%
519,825 $55.3 Million
Q4 2022

Jan 26, 2023
SELL
$87.44 - $112.11 $1.15 Million - $1.47 Million
-13,125 Reduced 2.45%
522,437 $0
Q3 2022

Oct 18, 2022
SELL
$84.53 - $94.96 $835,579 - $938,679
-9,885 Reduced 1.81%
535,562 $46.1 Million
Q2 2022

Jul 12, 2022
SELL
$83.49 - $94.64 $9.89 Million - $11.2 Million
-118,484 Reduced 17.85%
545,447 $49.7 Million
Q1 2022

Apr 19, 2022
SELL
$73.51 - $82.4 $2.52 Million - $2.82 Million
-34,260 Reduced 4.91%
663,931 $54.5 Million
Q4 2021

Jan 27, 2022
SELL
$72.28 - $90.54 $2.15 Million - $2.69 Million
-29,736 Reduced 4.09%
698,191 $53.5 Million
Q3 2021

Oct 14, 2021
SELL
$71.68 - $78.83 $257,617 - $283,315
-3,594 Reduced 0.49%
727,927 $54.7 Million
Q2 2021

Jul 19, 2021
BUY
$70.31 - $77.77 $5.71 Million - $6.31 Million
81,200 Added 12.49%
731,521 $56.9 Million
Q1 2021

Apr 28, 2021
BUY
$68.86 - $81.11 $777,222 - $915,488
11,287 Added 1.77%
650,321 $50.1 Million
Q4 2020

Jan 20, 2021
SELL
$71.77 - $79.65 $1.48 Million - $1.64 Million
-20,613 Reduced 3.12%
639,034 $52.3 Million
Q3 2020

Oct 29, 2020
SELL
$73.18 - $82.95 $9.71 Million - $11 Million
-132,684 Reduced 16.75%
659,647 $54.7 Million
Q2 2020

Jul 10, 2020
BUY
$70.42 - $80.13 $302,453 - $344,158
4,295 Added 0.55%
792,331 $61.3 Million
Q1 2020

Apr 13, 2020
SELL
$63.36 - $87.82 $23.6 Million - $32.7 Million
-371,803 Reduced 32.06%
788,036 $60.6 Million
Q4 2019

Jan 10, 2020
BUY
$77.58 - $87.54 $3.92 Million - $4.42 Million
50,499 Added 4.55%
1,159,839 $105 Million
Q3 2019

Oct 10, 2019
SELL
$76.08 - $82.93 $36.2 Million - $39.5 Million
-475,785 Reduced 30.02%
1,109,340 $93.4 Million
Q2 2019

Jul 24, 2019
SELL
$69.84 - $81.59 $684,012 - $799,092
-9,794 Reduced 0.61%
1,585,125 $133 Million
Q1 2019

Apr 10, 2019
SELL
$69.58 - $79.36 $4.49 Million - $5.12 Million
-64,489 Reduced 3.89%
1,594,919 $133 Million
Q4 2018

Jan 24, 2019
SELL
$65.24 - $75.71 $6.81 Million - $7.9 Million
-104,333 Reduced 5.92%
1,659,408 $127 Million
Q3 2018

Oct 10, 2018
SELL
$57.69 - $67.84 $2.99 Million - $3.52 Million
-51,817 Reduced 2.85%
1,763,741 $125 Million
Q2 2018

Jul 13, 2018
SELL
$50.83 - $59.72 $5.28 Million - $6.2 Million
-103,849 Reduced 5.41%
1,815,558 $110 Million
Q1 2018

May 01, 2018
BUY
$50.96 - $59.23 $75.2 Million - $87.4 Million
1,475,333 Added 332.23%
1,919,407 $105 Million
Q4 2017

Feb 05, 2018
BUY
$51.62 - $61.64 $22.9 Million - $27.4 Million
444,074
444,074 $25 Million

Others Institutions Holding MRK

# of Institutions
3,820
Shares Held
1.88B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Manning & Napier Group, LLC Portfolio

Follow Manning & Napier Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manning & Napier Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email